New Zealand's accelerating smoking decline: lessons for tobacco harm reduction Authors: Robert Beaglehole, Ruth Bonita, Ben Youdan Published: 2026 ABSTRACT SummaryFollowing implementation of key measures of the WHO Framework Convention on Tobacco Control (FCTC), adult smoking rates in New Zealand declined slowly. However, from 2018/19, smoking prevalence declined rapidly, coinciding with increased uptake of vaping following regulatory clarification and their endorsement as a cessation aid. Joinpoint regression analysis confirms this period as a statistically significant acceleration in decline compared with earlier trends. The reduction has been most pronounced among Māori and younger adults, consistent with higher uptake of vaping in these populations. Adult daily smoking has now plateaued at below 7%, reflecting an increasing concentration of smoking among Māori, older, and more socioeconomically disadvantaged groups. By contrast, youth smoking remains at historically low levels, and youth vaping has declined following regulatory tightening. New Zealand's experience suggests that harm reduction, implemented alongside FCTC measures and proportionate regulation, can accelerate declines in smoking while maintaining low youth smoking rates. Background Like many high-income countries, New Zealand experienced an epidemic of smoking-related disease beginning in the mid-20th century; by mid-century, 40% of men and one-third of women were smoking.1 Among Māori, the Indigenous population of New Zealand, smoking prevalence, particularly among women, was substantially higher and remained elevated for decades. These patterns contributed to marked inequalities in smoking-related disease with smoking being an important contributor to the life-expectancy gap between Māori and non-Māori.2 Early tobacco control efforts in New Zealand were incremental, partly due to the influence of the tobacco industry. Stimulated by non-governmental organisations, especially the Heart Foundation and Action on Smoking and Health (ASH), a comprehensive policy framework began to emerge with the introduction of the Smoke-free Environments Act in 1990, followed by the establishment of a national Quitline and subsidised nicotine replacement therapy.3 In 2004, New Zealand ratified the FCTC and gradually implemented a wide range of demand-reduction measures, including smoke-free public spaces, graphic health warnings, plain packaging, and, beginning in 2010, a decade of substantial annual tobacco excise increases. In 2011, in response to a Parliamentary report from the Māori Affairs Select Committee, the government adopted the Smokefree 2025 goal with a target of a very low daily total population smoking prevalence, subsequently accepted as meaning below 5%, and later, extended to all population groups.4 Despite these measures, smoking prevalence declined only gradually. By 2015/16, 15% of the adult population and 36% of Māori smoked daily. This trajectory changed after 2018/19 (Fig. 1).5 At the pre-2018 rates of decline, New Zealand would not have approached the Smokefree goal for several decades.6Fig. 1Long term trends in daily smoking prevalence among Māori and all adults aged 15 years and over, New Zealand, 2002/03–2024/25. Long term trends in daily smoking prevalence among Māori and all adults aged 15 years and over, New Zealand, 2002/03–2024/25. The emergence of vaping and harm reduction From 2019/20, a substantial vaping market emerged in New Zealand. Initially, the regulatory status of nicotine-containing vaping products was ambiguous, and enforcement was limited. A pivotal legal decision clarified that existing bans on oral tobacco did not apply to vaping devices, facilitating rapid market expansion.7 In 2019, the Ministry of Health recognised vaping as a substantially less harmful alternative to smoking and endorsed its use as a smoking cessation aid.8 The importance of protecting non-smokers, particularly young people, was emphasised while recognising that nicotine itself is not the cause of smoking-related disease.9 Legislation and regulation to control vaping as a consumer product was informed by evidence from New Zealand-based trials, international cessation studies and risk assessments comparing vaping with smoking.10, 11, 12 Following this period, smoking prevalence declined at an unprecedented rate: Māori smoking rates halved in six years and smoking in the total population fell below 7% in all adults by 2022/23 and has plateaued over the last three years.5 These reductions exceeded those observed over preceding decades under conventional FCTC policies. Adult daily vaping prevalence increased from under 1% in 2015 to approximately 12% by 2024/25 in the total population (Fig. 2). Among Māori, vaping prevalence rose more steeply, reaching approximately 28% by 2023/24. In both groups, rapid increases in vaping prevalence coincided with the accelerated rate of decline in smoking after 2018/19. Although these patterns do not imply causality, there is a close temporal alignment between vaping uptake and accelerated smoking decline, followed by a slowing in both trends. This pattern is consistent with diffusion of innovation theory,13 whereby adoption of a less harmful alternative spreads rapidly through early-adopting populations before reaching more resistant groups.Fig. 2Trends in daily smoking and vaping prevalence among Māori and all adults aged 15 years and over, New Zealand, 2011/12–2024/25. Trends in daily smoking and vaping prevalence among Māori and all adults aged 15 years and over, New Zealand, 2011/12–2024/25. Joinpoint regression analyses were conducted to determine whether the observed changes represented statistically distinct shifts rather than continuation of prior trends.14 These analyses identified distinct and statistically significant changes in the rate of decline in adult smoking (Supplementary Table). Among the total population (ie all adults aged 15 years and over), two joinpoints were identified in 2018/19 and 2022/23. Smoking prevalence declined modestly up to 2018/19 (annual percent change (APC) −3.5%, p < 0.00001), followed by a period of rapid decline from 2018/19 to 2022/23 (APC −17.9%, p < 0.00001), a five-fold increase in the annual rate of decline. Since 2022/23, this decline has plateaued, with no statistically significant changes observed. Among Māori adults, a single joinpoint was identified in 2018/19. Smoking prevalence declined modestly prior to this point (APC −2.2%, p < 0.00001), followed by a marked acceleration in the rate of decline through to 2024/25 (APC −13.3%, p < 0.00001), representing a five-fold increase in the annual rate of decline. These findings confirm that the post-2018/19 period represents a discrete and statistically significant acceleration in smoking decline rather than continuation of earlier trends. Although ecological analyses cannot establish causality, the combination of a clear structural break in trend, temporal alignment with increased uptake of vaping strengthens the plausibility of a contributory effect. Although other tobacco control measures, including sustained excise increases and plain packaging were implemented prior to 2018, they were associated with gradual, not accelerated declines, making them unlikely to account for the observed structural change for both Māori and the total population. In England, the association of plain packaging with smoking reduction occurred in anticipation of, rather than after full policy implementation.15 The comparison with Australia, which has had similar success with FCTC implementation but even higher tax rates, is instructive. Australia has a much more restricted approach to accessing vapes, and the illicit trade in both vapes and cigarettes has flourished.16 Youth smoking and vaping Youth patterns of smoking are also encouraging. Daily smoking among 15–25 year-olds has almost been almost eliminated. In younger teenagers aged 14–15, the daily smoking rate has halved to 1% since 2015, although ethnic and socio-economic inequalities continue.17 Overall nicotine use among young people is higher than in the absence of vaping; around 14% of 15–17-year-olds reported daily nicotine use—mainly vaping–in 2024/25 compared to 3.4% in 2017/18.5 Notably, much of the increase in vaping–including among non-smokers–occurred before 2021, when New Zealand had no legislative controls on the vaping market or products.18 At an individual level, people who vape appear to be more likely to go on to smoke than people who do not vape, but it is unclear if these behaviours are causally linked.19 Interrupted time-series analyses of New Zealand data have suggested that the decline in regular youth smoking may have slowed after vaping emerged.20,21 Nonetheless, daily youth smoking remains very low and shows no sign of increasing, which suggests that there is little, if any, serious progression from vaping to smoking.22 After vaping regulations came into force in 2021, including both age limits on legal sales (18 years) and restricted access to sales, declines in youth daily vaping occurred from the peak of 10% in 2022 to 7% in 2025, and regular youth vaping has declined from a peak of 20% in 2021 to 11% in 2025.18 The regulations have been tightened on several occasions to reduce the appeal of vapes, reduce the range of flavours, prohibit disposable products, and reduce the nicotine content of vapes. Importantly, the acceleration in adult smoking decline occurred in the context of continued reductions in youth smoking, suggesting that increased availability of vaping, with appropriate regulation, did not translate into increased smoking uptake among young people at the population level. New Zealand's experience suggests that adult smoking can decline rapidly and youth vaping can be reduced through regulation and evidence-based educational interventions. Continued monitoring of youth nicotine use remains essential to ensure that reductions in smoking are not offset by unintended long-term harms. Equity, age gradients and the persistence of smoking The acceleration in national smoking decline after 2018/2019, especially in Māori, suggests that harm reduction acted most strongly where smoking prevalence was highest. Disaggregation by ethnicity, neighbourhood deprivation, and age provides insight into the recent plateau in smoking prevalence. Māori and adults living in the most deprived neighbourhoods experienced the greatest absolute reductions in smoking prevalence after 2019/20, with declines exceeding those observed in the total population.5 These parallel trends reflect substantial overlap between Māori ethnicity and socioeconomic deprivation, while also indicating that the accelerated decline was not confined to Māori alone. Age-specific analyses show that smoking prevalence declined most rapidly among younger adults. In contrast, declines among adults aged 45 years and older were slower and occurred later. By the mid-2020s, more than half of remaining smokers were aged over 45 years; smoking has become increasingly concentrated among older adults within Māori and high-deprivation populations.5 This compositional shift provides a coherent explanation for the recent plateau in smoking prevalence and is consistent with a saturation effect, whereby rapid early declines are followed by slower progress among more dependent and harder-to-reach populations who are less responsive to existing approaches, thereby slowing population-level decline. Sustaining momentum towards the smokefree goal As smoking prevalence declines, further progress will depend on precision rather than additional population-wide measures together with a well informed public. New Zealand's remaining smoking burden is increasingly concentrated among Māori, people living in the most deprived communities, and predominantly older adults with long smoking histories. For these people, targeted and compassionate equity-focused harm-reduction and cessation strategies–supported by regulation proportionate to risk–are essential. Failure to align tobacco control strategies–particularly harm reduction strategies–with the populations where smoking is most concentrated, risks slowing further declines and entrenching existing health inequalities. The Smokefree 2022 legislation included substantial supply-side measures reducing the number of tobacco retail outlets and mandating denicotinisation of smoked tobacco products. At the time, the responsible Minister noted that vaping was part of the policy framework, as it provided alternatives for smokers.6 This legislation was repealed in early 2024 before it was implemented. Importantly, the subsequent plateau in smoking prevalence predates the repeal and is better explained by changes in the composition of the remaining smoking population. Conclusions New Zealand's experience highlights several lessons for tobacco control. First, implementation of the FCTC is important but not sufficient to achieve very low smoking prevalence. Second, harm reduction—through regulated access to substantially less harmful smokefree nicotine products—can complement demand and supply reduction policies and accelerate reductions in exposure to combustible tobacco, particularly among people with the greatest burden of tobacco-related harm. This approach is consistent with a focus on reducing the harms caused by smoking, while recognising that eliminating nicotine is a separate objective and would require different policy considerations. In New Zealand, a widening price differential between cigarettes and vapes has reinforced switching incentives. Third, reductions in adult smoking can occur alongside declines in youth smoking and vaping when regulation is timely, proportionate and enforced. Finally, the New Zealand experience suggests that the diffusion of less harmful smokefree nicotine products, especially vapes, may have contributed to the observed acceleration in smoking decline. The recent plateau in smoking rates should therefore be interpreted not as failure, but as reflecting a transition to more concentrated and under-served communities. Maintaining a clear focus on reducing harm from combustible tobacco will be critical to sustaining progress as smoking prevalence declines. Further progress will require compassionate and targeted equity-focused interventions and a coherent regulatory framework that covers all nicotine products in proportion to the risks they incur. Contributors RB prepared the first draft. All authors contributed to the revisions. RBon and BY prepared the figures. BY undertook the statistical analysis. Declaration of interests None.